STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1814 by analyst upside · 2026-06-27
ANGO
AngioDynamics, Inc.
Healthcare · Market Cap $554M · P/E 0x
ANALYST PRICE TARGET
+34.3%
implied upside to consensus target
Current Price $13.4
Consensus Target $18.0
Bull Target $24.0
Bear Target $16.0
Analysts Covering 4
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
4
Hold
0
Sell
0
52-Week Low $8.36
52-Week High $13.99
YTD Return +5.7%
FUNDAMENTALS
Market Cap $554M
P/E Ratio (TTM) N/A
Forward P/E -60.9x
EPS (TTM) $-0.74
PEG Ratio 1.41
Dividend Yield N/A
Revenue (TTM) $314M
Profit Margin -10.0%
52-WEEK RANGE
52-Week Low $8.36
52-Week High $13.99
Current Price $13.4
Bear Target $16.0
Bull Target $24.0
● Now $13.4 ● Target $18.0
TRADING DATA
Avg Volume 393K
YTD Return +5.7%
Analyst Count 4
Consensus Buy
Upside to Target +34.3%
Last Updated 2026-06-27

ANALYST SUMMARY

AngioDynamics, Inc. (ANGO) is currently trading at $13.4 with a Wall Street consensus price target of $18.0, implying potential upside of 34.3% over the next 12 months. 4 analysts currently cover ANGO, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $24.0, while the most cautious has a target of $16.0.

ANGO operates in the Healthcare sector with a market capitalisation of $554M. The stock is up 5.7% year-to-date and is currently trading near the upper end of its 52-week range of $8.36 – $13.99.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for ANGO, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Canaccord Genuity — Reiterated
Buy → Buy 2026-04-06 Building track record
Freedom Broker ● Initiated
Buy 2026-04-06 Building track record
Canaccord Genuity — Reiterated
Buy → Buy 2025-10-03 Building track record
Lake Street ● Initiated
Buy 2025-07-16 27% win rate (11 calls)
HC Wainwright & Co. reit
Buy → Buy 2025-07-16 31% win rate (48 calls)
Canaccord Genuity — Reiterated
Buy → Buy 2025-07-16 Building track record
HC Wainwright & Co. — Reiterated
Buy → Buy 2025-04-07 31% win rate (48 calls)
HC Wainwright & Co. — Reiterated
Buy → Buy 2025-01-10 31% win rate (48 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
57
out of 100
Coverage depth
12/30
Consensus clarity
18/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →